Skip to content

Effects of treatment of painful shoulder muscle nodules on shoulder pain, mobility, and muscle function in individuals with shoulder pain

Effects of ischemic compression therapy at myofascial trigger points on pain, mobility, and muscle function of the shoulder complex in individuals with shoulder pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3ddg2k
Enrollment
Unknown
Registered
2018-07-10
Start date
2017-05-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder pain

Interventions

Intervention study Single-arm, quasi-experimental, self-controlled.The research will have 20 subjects. The search should take place in two days. Three evaluations will be carried out: a) first day, i
(B) second day, 48 hours after the initial assessment
and c) immediately after the intervention. Three evaluators will be performe the assessments: one will carry out the evaluation for the screening of the individuals recruited, another evaluator will
2) verification of TrPMs
3) pain threshold at pressure
4) mobility
and 5) isometric strength of the shoulder in the elevation of the arm in the plane of the scapula, medial and lateral rotation of the shoulder. For the identify of the trigger points the following pr
Other
E02.779
E02.190.599

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Presence of at least one active or latent PGM, on the symptomatic side, in one of the following muscles: upper trapezius, lower trapezius, supraspinatus, infraspinatus, minor pectoris and middle deltoid.The subjects should have a history of unilateral shoulder pain, lasting more than one week, located in the proximal anterolateral region of the shoulder, or in the C5 or C6 dermatome region; Least three of the special tests for SIS diagnosis considered positive: Neer test; Hawkins' test; Jobe's test; Painful arch test; External rotation resistance test; Gerber test and Speed biceps test.

Exclusion criteria

Exclusion criteria: Signs and symptoms of bilateral SIS;Primary adhesive capsulitis; Reproduction of shoulder pain which radiates to the entire upper limb; Numbness or tingling in the upper limb or any other symptom in the upper limb during foraminal compression test; History of symptom onset due to glenohumeral displacement or subluxation; Joint deformation in the glenoid or humeral head; Or fracture of the clavicle, scapula or humerus;History of surgical stabilization or repair of the rotator cuff;Groove test or positive seizure test;Signs of complete rupture of the rotator cuff, as evidenced by the positive fall test; Systemic disease involving joints such as rheumatoid arthritis and systemic lupus erythematosus and fibromyalgia, which involves myofascial tissue;Neurological pathologies; Use of analgesics and muscle relaxants 72 hours before the evaluation;Use of corticoid injection 3 months prior to evaluation;Body mass index (BMI)> 28kg /m2;Symptoms of depression, with score 13 in the Beck Depression Inventory;Be there for a period of 1 month without participating in any program of physiotherapeutic treatment, stretching, strengthening or specific resistance exercises for the upper limbs.

Design outcomes

Primary

MeasureTime frame
Expected endpoint: increased pain pressure threshold verified from a digital algometer that exceeds the values of minimum detectable change (MMD) to 95% of each muscle: 0.6 kgf / cm2, upper trapezius; 0.88 kgf / cm 2, lower trapezoid; 1.06kgf / cm2, infraespinal; 0.74 kgf / cm 2, medium deltoid. The values were obtained through training prior to the study to perform the isometric strength evaluation.

Secondary

MeasureTime frame
Expected: decrease in the number of trigger points (active and latent), evaluated by the manual identification of the second rater. ;Expected Outcome: increase in pain-free range of motion, assessed through the digital inclinometer. For minimal detectable change (MDC) at 90%, the following will be considered: minimum clinical change of ADM: 3,4 ° for flexion; 9.29 ° for internal rotation and 16.95 ° for external rotation. The values of MDC were obtained through training training prior to the study to perform the isometric strength assessment. ;Expected outcome: increased isometric force of scapular flexion, external rotation and internal rotation. For the minimum detected change (MDC) at 90%, it will be considered: internal rotation of 21.57; external rotation of 15.54; and scapular flexion of 12.78. The values of MDC were obtained through training training prior to the study to perform the isometric strength assessment.

Countries

Brazil

Contacts

Public ContactJose Diego Nascimento

Universidade Federal do Rio Grande do Norte

zediegofisio@gmail.com+55-083-999725806

Outcome results

None listed

Source: REBEC (via WHO ICTRP)